<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://updates.zdnet.com/">
<channel>
	<title><![CDATA[drug company Resources | ZDNet]]></title>
	<link><![CDATA[http://updates.zdnet.com/tags/drug+company.html]]></link>
	<description><![CDATA[White papers, case studies, technical articles, and blog posts relating to drug company]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Canadians get a taste of American medical system with IMS Health buy]]></title>
		<link><![CDATA[http://talkback.zdnet.com/5208-13593-0.html?forumID=1&threadID=71323&messageID=1375332&start=0]]></link>
		<description><![CDATA[Oh the ironyJust another ironic investment made on behalf of Canadians over the years.  As far as I know CPP is not investing using an ethical or green model, so there are probably lots of examples of very "un-Canadian" companies receiving investment via CPP.Not sure what your point is,...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Fri, 06 Nov 2009 08:23:00 -0800</pubDate>
		<category domain="http://updates.zdnet.com/tags/vertical+industries.html"><![CDATA[Vertical industries]]></category>
		<category domain="http://updates.zdnet.com/tags/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://updates.zdnet.com/tags/ims+health+inc..html"><![CDATA[IMS Health Inc.]]></category>
		<category domain="http://updates.zdnet.com/tags/cpp.html"><![CDATA[CPP]]></category>
		<category domain="http://updates.zdnet.com/tags/dana.html"><![CDATA[Dana]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[drug company]]></category>
		<category domain="http://updates.zdnet.com/tags/obama.html"><![CDATA[Obama]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RX</category>
		<category domain="tickers">RX</category>
	</item>
	<item>
		<title><![CDATA[Should drug companies know what the doctor prescribed]]></title>
		<link><![CDATA[http://talkback.zdnet.com/5208-13593-0.html?forumID=1&threadID=64408&messageID=1197908&start=0]]></link>
		<description><![CDATA[Should drug companies know what the doctor prescribedI'll go with the docs on this oneFirst look at the potential use of the data.  You really need to know the patient's age, sex and race as well as their medical condition.  Then throw in the other medications that the...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Mon, 11 May 2009 19:57:00 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/patient.html"><![CDATA[patient]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[drug company]]></category>
	</item>
	<item>
		<title><![CDATA[Preemption case went before Supremes today]]></title>
		<link><![CDATA[http://healthcare.zdnet.com/?p=1489]]></link>
		<description><![CDATA[My feeling is that this will lead to illness and death that become matters for the criminal courts. Wyeth executives who skated in civil court, thanks to their friends in Washington, may find themselves behind bars one day. by Dana Blankenhorn]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 03 Nov 2008 11:25:00 -0800</pubDate>
		<category domain="http://updates.zdnet.com/tags/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
		<category domain="http://updates.zdnet.com/tags/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://updates.zdnet.com/tags/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://updates.zdnet.com/tags/side+effect.html"><![CDATA[Side Effect]]></category>
		<category domain="http://updates.zdnet.com/tags/bush+plan.html"><![CDATA[Bush Plan]]></category>
		<category domain="http://updates.zdnet.com/tags/legal+times.html"><![CDATA[Legal Times]]></category>
		<category domain="http://updates.zdnet.com/tags/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://updates.zdnet.com/tags/professional+development.html"><![CDATA[Professional Development]]></category>
		<category domain="http://updates.zdnet.com/tags/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://updates.zdnet.com/tags/government.html"><![CDATA[Government]]></category>
		<category domain="http://updates.zdnet.com/tags/career.html"><![CDATA[Career]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
	<item>
		<title><![CDATA[The tech trend killing the drug industry]]></title>
		<link><![CDATA[http://healthcare.zdnet.com/?p=1453]]></link>
		<description><![CDATA[Biologicals are forcing policymakers around the world to ask the hard questions. Should cost cause some citizens to die? Where is the line drawn? Is the private market the best way to deliver these medicines? by Dana Blankenhorn]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 22 Oct 2008 09:07:56 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/biologicals.html"><![CDATA[Biologicals]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://updates.zdnet.com/tags/management.html"><![CDATA[Management]]></category>
		<category domain="http://updates.zdnet.com/tags/policymaker.html"><![CDATA[Policymaker]]></category>
		<category domain="http://updates.zdnet.com/tags/security.html"><![CDATA[Security]]></category>
		<category domain="http://updates.zdnet.com/tags/shotgun.html"><![CDATA[Shotgun]]></category>
		<category domain="http://updates.zdnet.com/tags/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[Drug profit incompatible with scientific method?]]></title>
		<link><![CDATA[http://talkback.zdnet.com/5208-13593-0.html?forumID=1&threadID=51526&messageID=968537&start=0]]></link>
		<description><![CDATA[Drug profit incompatible with scientific method?Patentability and ProfitThe problem with new drugs like Vytorin is that we must rely on short-term studies & short-term observation in order to gamble on the drugs' safety. There is, presently, only one cholesterol medication that has not only proven to be most effective in...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Wed, 03 Sep 2008 10:29:00 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/tobacco.html"><![CDATA[tobacco]]></category>
		<category domain="http://updates.zdnet.com/tags/new+drug.html"><![CDATA[new drug]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[drug company]]></category>
	</item>
	<item>
		<title><![CDATA[Genentech deal shows drug companies are oil drillers]]></title>
		<link><![CDATA[http://healthcare.zdnet.com/?p=1161]]></link>
		<description><![CDATA[The problem is we're finding, as the science of DNA advances, that there are few easy answers. A drug which works for one person may not work for others. Side-effects are worsening for those whose genetic code rejects a new substance. by Dana Blankenhorn]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 21 Jul 2008 06:35:16 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://updates.zdnet.com/tags/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://updates.zdnet.com/tags/side-effects.html"><![CDATA[Side-effects]]></category>
		<category domain="http://updates.zdnet.com/tags/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://updates.zdnet.com/tags/wiki.html"><![CDATA[Wiki]]></category>
		<category domain="http://updates.zdnet.com/tags/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://updates.zdnet.com/tags/online+communications.html"><![CDATA[Online Communications]]></category>
		<category domain="http://updates.zdnet.com/tags/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="tickers">DNA</category>
	</item>
	<item>
		<title><![CDATA[Do drug companies need government subsidies?]]></title>
		<link><![CDATA[http://talkback.zdnet.com/5208-13593-0.html?forumID=1&threadID=45923&messageID=848230&start=0]]></link>
		<description><![CDATA[Do drug companies need government subsidies?You don't get to receive welfare AND rape your customersPick one or the other. Not both.RE: Do drug companies need government subsidies?Of course they do.  How else can they prove that they can't compete on a world stage and still satisfy shareholders?  Maybe...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Tue, 25 Mar 2008 07:45:00 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/taxes.html"><![CDATA[Taxes]]></category>
		<category domain="http://updates.zdnet.com/tags/free+trade.html"><![CDATA[Free trade]]></category>
		<category domain="http://updates.zdnet.com/tags/government+subsidy.html"><![CDATA[government subsidy]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[drug company]]></category>
	</item>
	<item>
		<title><![CDATA[Digital signatures at heart of health care reform debate]]></title>
		<link><![CDATA[http://healthcare.zdnet.com/?p=397]]></link>
		<description><![CDATA[Privacy and security are top-of-mind when anyone talks about technology enabling health care reform.    The solution, according to R. â€˜Docâ€™ Vaidhyanathan, vice president of product management for Arcot Systems in Sunnyvale, is to maintain encryption keys in a central store, than have doctors, pharmacists, and drug companies...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 25 Oct 2007 12:35:11 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/digital+signature.html"><![CDATA[Digital Signature]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://updates.zdnet.com/tags/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://updates.zdnet.com/tags/arcot+systems.html"><![CDATA[Arcot Systems]]></category>
		<category domain="http://updates.zdnet.com/tags/key.html"><![CDATA[Key]]></category>
		<category domain="http://updates.zdnet.com/tags/digital+signatures.html"><![CDATA[Digital Signatures]]></category>
		<category domain="http://updates.zdnet.com/tags/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://updates.zdnet.com/tags/authentication%252fencryption.html"><![CDATA[Authentication/Encryption]]></category>
		<category domain="http://updates.zdnet.com/tags/digital+security.html"><![CDATA[Digital Security]]></category>
		<category domain="http://updates.zdnet.com/tags/security.html"><![CDATA[Security]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
	</item>
	<item>
		<title><![CDATA[EU questions iTunes pricing]]></title>
		<link><![CDATA[http://talkback.zdnet.com/5208-9588-0.html?forumID=1&threadID=8504&messageID=170954&start=0]]></link>
		<description><![CDATA[EU questions iTunes pricingSo what?It may be a questionable business practice to charge customers in the UK more than other EU customers (p*ssing off your customers is usually a bad idea), but why would it be illegal?U.S. drug companies charge more in the U.S.A. than they do in Canada and...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Fri, 25 Feb 2005 06:31:00 -0800</pubDate>
		<category domain="http://updates.zdnet.com/tags/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://updates.zdnet.com/tags/pricing+strategy.html"><![CDATA[pricing strategy]]></category>
		<category domain="http://updates.zdnet.com/tags/drug+company.html"><![CDATA[drug company]]></category>
		<category domain="http://updates.zdnet.com/tags/itunes+pricing.html"><![CDATA[iTunes pricing]]></category>
		<category domain="http://updates.zdnet.com/tags/apple+inc..html"><![CDATA[Apple Inc.]]></category>
		<category domain="http://updates.zdnet.com/tags/member+state.html"><![CDATA[member state]]></category>
		<category domain="http://updates.zdnet.com/tags/apple+itunes.html"><![CDATA[Apple iTunes]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AAPL</category>
		<category domain="tickers">AAPL</category>
	</item>
</channel>
</rss>
